# In vitro evaluation of a new balloon design to treat calcified stenosis

**Authors:** Oliver Andrew Binkert, Christoph Andreas Binkert, Thomas Frauenfelder

PMC · DOI: 10.1186/s42155-026-00662-2 · CVIR Endovascular · 2026-02-28

## TL;DR

A new balloon design called WAVE creates more and smaller fragments in calcified arteries, potentially improving angioplasty outcomes.

## Contribution

The WAVE balloon design with a segment-waist stress pattern and procedural adjustments is introduced for treating calcified stenosis.

## Key findings

- The WAVE concept generated significantly more fragments (112.6) compared to standard PTA (48.6).
- The WAVE concept produced fewer fragments larger than 9 mm (7.6) compared to standard PTA (13.2).
- The WAVE concept shows potential to improve angioplasty outcomes in calcified lesions.

## Abstract

Standard percutaneous transluminal angioplasty (PTA) occasionally falls short in sufficiently treating calcified lesions in below the knee arteries.

To address this, a new balloon design, called WAVE, was developed. This balloon is divided into multiple smaller segments, thereby creating a segment-waist shaped stress pattern. In combination with a procedural adjustment, involving three inflation cycles and a slight shift of the balloon between each inflation, the WAVE concept is proposed, in which enhanced fragmentation of calcified lesions is hypothesized.

A comparison between the standard of care PTA and the WAVE concept was made to evaluate the potential benefit of implementing the WAVE concept.

The experiment was evaluated using a calcified arterial in vitro model. The primary endpoint was to assess and compare both the total number of fragments and the number of fragments larger than 9 mm generated by the WAVE concept (including three inflations) versus the standard PTA (standard balloon with a single inflation).

The WAVE concept generated a significantly higher total number of fragments (112.6; 95% CI [103.3, 121.9]) compared to the standard balloon after a single inflation (48.6; 95% CI [42.5, 54.7]) (p < 0.001). The number of fragments exceeding 9 mm was significantly lower with the WAVE concept (7.6; 95% CI [6.4, 8.8]) compared to standard PTA (13.2; 95% CI [11.6, 14.8]) (p < 0.001).

The WAVE concept creates more and smaller fragments in a below-the-knee calcified arterial in vitro model. These findings show promising potential to improve the outcomes of future angioplasty procedures.

## Full-text entities

- **Genes:** SUGP1 (SURP and G-patch domain containing 1) [NCBI Gene 57794] {aka F23858, RBP, SF4}, BTK (Bruton tyrosine kinase) [NCBI Gene 695] {aka AGMX1, AT, ATK, BPK, IGHD3, IMD1}
- **Diseases:** ischemia (MESH:D007511), BTK stenosis (MESH:D003251), arteriopathy (MESH:D020212), hyperlipidemia (MESH:D006949), WAVE (OMIM:245570), fracture (MESH:D050723), calcification (MESH:D002114), vessel injury (MESH:C536223), diabetes (MESH:D003920), Arterial lesions (MESH:D020765), CLTI (MESH:D000089802), renal disease (MESH:D007674), PAD (MESH:D058729), intimal hyperplasia (MESH:D006965), calcified (MESH:D018333), MAC (MESH:D050380), restenosis (MESH:D023903), calcification of arteries (MESH:D061205), hypertension (MESH:D006973), occlusions (MESH:D001157), limb loss (MESH:D001259), ischemic foot (MESH:D005530), arterial stenoses (MESH:D012078)
- **Chemicals:** water (MESH:D014867), silicone (MESH:D012828), NaCl (MESH:D012965), Visipaque (MESH:C044834), paraffin wax (MESH:D010232), CaCO3 (MESH:D002119), nitinol (MESH:C013616), iodine (MESH:D007455), lipids (MESH:D008055), calcium (MESH:D002118), carnauba wax (MESH:C026344), IVL (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12950118/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12950118/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12950118/full.md

---
Source: https://tomesphere.com/paper/PMC12950118